False positive reaction of COVID-19 antibody ELISA screening: internal logic of various methods

Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 12

Abstract

Objective To analyze the results of different methods for reactive samples screened by the enzyme linked immunosorbent assay (ELISA) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in blood donors. Methods From March to April 2020, a total of 8 632 blood samples in Shenzhen were screened for SARS-CoV-2 total antibodies (TAb, including IgG, IgM, IgA) in plasma using ELISA(PC group), the antibody reactivity samples and their follow up plasma samples (FC group), and samples of disease control group(DC group) from January to April 2020 were detected using the following methods: 1) ELISA method for detecting IgG, IgM, and (or without detection) TAb; 2) pseudovirus neutralizing antibody test(pVNT); 3) western blot (WB) of SARS-CoV-2 antibody. The negative control group(NC group) from February to April 2020 performed ELISA and WB testing. Results Among the 34 total antibody positive samples, 2 were positive for pVNT test, and the total antibody, IgG and WB in the initial screening and tracking testing were positive. Thereafter, it was determined to be confirmed positive. The other 2 cases were positive for pVNT test, while the samples with positive WB results were in the follow-up stage. The TAb, IgG, and pVNT results did not conform to the dynamic evolution of antibodies, and cannot be determined as confirmed positive. Conclusion The infection status of antibody reactivity samples screened by SARS-CoV-2 ELISA can be judged by the logic of pVNT, WB and the dynamic change of antibody.

Authors and Affiliations

Lilin WANG, Ran LI, Tong LI, Aijia ZHANG, Heng LIU, Xiaoxuan XU, Jinfeng ZENG, Linfeng WU

Keywords

Related Articles

Blood group serology and gene detection in patients with B(A) subgroup in Jiaozhou, Qingdao

Objective To investigate and analyze the serological and molecular biological characteristics of B(A) subgroup in a tertiary hospital in Jiaozhou, Qingdao. Methods From November 2019 to February 2023, the samples of 12 p...

Analysis of donation related vasovagal reactions in Hefei

Objective To explore the influencing factors and characteristics of blood donation-related vasovagal reactions in whole blood donation in Hefei city, and to put forward specific prevention measures. Methods Whole blood d...

Effect of RhD antigen expression intensity on preparation of low positive quality control products for transfusion compatibility test

Objective To determine the reference red blood cells with weak agglutination intensity of low positive quality control products by comparing RhD antigen expression intensity difference according to the serological result...

Analysis on phenotype and genotyping of CisAB subtypes: 12 Cases

Objective To analyze and master the serological and genetic characteristics of the samples with CisAB subtype and their genetic background. Methods From January 2018 to January 2022, blood samples with discrepant ABO blo...

Blood consumption and clinical prognosis in patients with massive blood transfusion: a retrospective analysis

Objective To investigate the incidence of clinical massive blood transfusion in hospitals, the proportion of departments conducted massive blood transfusion and the current situation of component transfusion, so as to pr...

Download PDF file
  • EP ID EP738710
  • DOI 10.13303/j.cjbt.issn.1004-549x.2023.12.001
  • Views 53
  • Downloads 0

How To Cite

Lilin WANG, Ran LI, Tong LI, Aijia ZHANG, Heng LIU, Xiaoxuan XU, Jinfeng ZENG, Linfeng WU (2023). False positive reaction of COVID-19 antibody ELISA screening: internal logic of various methods. Chinese Journal of Blood Transfusion, 36(12), -. https://europub.co.uk/articles/-A-738710